US Stock Market Move | Optimi Health (OPTH.US) debuts on the US stock market with an opening price drop of over 13%.
Optimi Health has entered the US stock market, with its opening price dropping by more than 13%, at $6.1 per share.
On Wednesday, Optimi Health (OPTH.US) made its debut on the US stock market, with the opening price falling over 13% to $6.1. The IPO price was $7.05. Optimi Health is a pharmaceutical company from Canada, focusing on the production of MDMA and Psilocybin drug products for mental health treatment. The company is headquartered in British Columbia, Canada, and has a GMP drug production facility licensed by Health Canada.
Related Articles
On May 20, Bretton (01333) will convert 106 million A shares into 106 million H shares.
US Stock Market Move | Amass Brands (AMSS.US) debuts on the US stock market, opening with over a 20% decrease.
AI boom drives nuclear energy investment to heat up, underground nuclear reactor startup company Deep Fission (FISN.US) submits US stock IPO application, plans to issue 6 million common shares.
On May 20, Bretton (01333) will convert 106 million A shares into 106 million H shares.
US Stock Market Move | Amass Brands (AMSS.US) debuts on the US stock market, opening with over a 20% decrease.
AI boom drives nuclear energy investment to heat up, underground nuclear reactor startup company Deep Fission (FISN.US) submits US stock IPO application, plans to issue 6 million common shares.
